Myasthenia gravis is not an incurable disease. Generally, the prognosis of patients is good, and only patients with myasthenia gravis crisis have a higher mortality rate. Myasthenia gravis refers to the dysfunction of nerve-muscle joint transmission, which is an acquired autoimmune disease. At present, there are many treatments for myasthenia gravis, such as oral drugs, such as cholinesterase inhibitors; Adrenal cortical hormone can also be used, including shock therapy and small dose escalation; Immunosuppressants such as cyclophosphamide and azathioprine; If the patient has thymic hypertrophy, high serum acetylcholine receptor antibody titer, or myasthenia gravis with thymoma, thymoma can be treated with thymus, and about 70% of the patients can be relieved or cured after operation, so the prognosis of patients with myasthenia gravis who are actively treated is optimistic.

Myasthenia gravis belongs to immune diseases of nervous system. There are also some mild myasthenia gravis, such as patients with ocular myasthenia gravis, ptosis and diplopia. A few patients with this type of myasthenia gravis may heal themselves, but they should be followed up regularly, and there may be signs of recurrence.

For most patients with myasthenia gravis, self-healing is very difficult, and the symptoms usually worsen progressively, especially for some patients with generalized myasthenia gravis, which may cause general weakness, swallowing dysfunction and other symptoms. Such patients must seek medical treatment as soon as possible. The treatment is mainly using some cholinesterase inhibitors and glucocorticoids. The application of hormones is very knowledgeable, and it takes a period of time to gradually increase and then gradually decrease, so regular follow-up is very important.